Mother Joseph Plaza
9427 SW Barnes Road - Suite 595
Phone: 503-291-5300
Fax: 503-291-5303

Special Considerations
for Women with Epilepsy

Mark S. Yerby M.D., M.P.H.
Clinical Associate Professor of Neurology, Public Health and Ob-Gyn
Oregon Health Sciences University

References

Herkes GK, Eadie MJ, Shargrough F, Moyer T. Patterns of seizure occurrence in catamenial epilepsy. Epilepsy Research 1993;15:47-52.

Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia 1997;38(10):1082-1088.

Lundberg PO. Catamenial epilepsy: a review. Cephalgia 1997;17 (Suppl 20):42-45.

Bonuccelli U, Melis GB, Paoletti AM, Fioretti P, Murri L, Muratorio A. Unbalanced progesterone and estradiol secretion on catamenial epilepsy. Epilepsy Res. 1989;3:100-106.

Narbone MC, Ruello C, Oliva A, Baviera G, DíAminco D, Bramanti P, DiPerri R. Hormonal disregulation and catamenial epilepsy. Functional Neurology 1990;5(1):49-53.

Shavit G, Lerman P, Korczyn AD, Kivity S, Bechar M, Gitter S. Phenytoin pharmacokinetics in catamenial epilepsy. Neurology 1984;34:959-61.

Kumar N, Behari M, Ahuja GK, Jailkahani BL. Phenytoin levels in catamenial epilepsy. Epilepsia 1988;29(2):155-158.

Murialdo G, Galimberti CA, Gianelli MV, Rollero A, Polleri A, Copello F, Magri F, Ferrari E, Sampaolo P, Manni R, Tarara A. Effects of valproate, phenobarbital and carbamazepine on sex steroid setup in women with epilepsy. Clinical Neuropharmacology 1998;21(1):52-58.

Mattson RH, Cramer JA, Caldwell BV, Siconolfi BC. Treatment of seizures with medroxyprogesterone acretate; Preliminary report. Neurology 1984;34:1255-58.

Zimmerman AW, Holden KR, Reiter EO, Dekaban AS. Medroxyprogesterone acetate in the treatment of seizures assoictaed with menstruation. J. Pediatr 1973;83:959-63.

Herzog AG, Progesterone therapy in women with complex partial and secondarily generalized seizures. Neurology 1995;45:1660-62.

Herzog AG, Clomiphene therapy in epileptic women with menstrual disorders. Neurology 1988;38:432-34.

Herzog AG, Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders. Neurology 1986;36:1607-10.

Dana Haeri J, Richens A. Effect of noresthisterone on seizures associated with menstruation. Epilepsia 1983;24:377-81.

Mattson RH, Cramer JA, Darney PD, Naftolin F. The Use of oral contraceptives by women with epilepsy. JAMA 1986;256(2):238-40.

Svigos JM. Epilepsy and pregnancy Aust NZ J Obstet Gynaecol 1984;24:182-185.

Yerby MS, Koepsell T, Daling J. Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia. 1985;26:631-635.

Trimble MR. Serum prolactin in epilepsy and hysteria. British Medical Journal 1978;2:1682.

Schupf N, Ottman R. 1994. Likelihood of pregnancy in individuals with idiopathic/cryptogenic epilepsy: social and biologic influences. Epilepsia. 35:(4):750-756.

Morrel MJ. Sexual dysfunction in epilepsy. Epilepsia 1991;32(Suppl 6):S38-46.

Bilo L, Meo R, Nappi C. 1988. Reproductive and endocrine disorders in women with primary generalized epilepsy. Epilepsia. 29:(5):612-619.

Isojarvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllyla VV. 1993. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. The New England Journal of Medicine. 329:(19):1383-1388.

Drislane FW, Coleman AE, Schomer DL, Ives J, Levesque LA, Seibel MM, Herzog AG. 1994. Altered pulstitile secretion of lutenizing hormone in women with epilepsy. Neurology. 44:306-310.

Sabin M, Oxorn H. 1956. Epilepsy and pregnancy. Obstetrics and Gynecology. 7:175-199.

Knight AH, Rhind EG. Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia. 1975;16:99-110.

Nau H, Kuhnz W, Egger HJ et al. 1981. Anticonvulsants during pregnancy and lactation: Transplacental, maternal and neonatal pharmacokinetics. Clinical Pharmacokinetics. 7:508-43.

Yerby MS, Friel PN, McCormick KB, Koerner M, VanAllen M, Leavitt AM, Sells CJ, Yerby JA. Pharmacokinetics of anticonvulsants in pregnancy: alterations in plasma protein binding. Epilepsy Research. 1990;5:223-228.

Dansky LV, Andermann E, Andermann F, Sherwin AL, Kinch RA. 1982. Maternal epilepsy and congenital malformations: Correlation with maternal plasma anticonvulsants levels during pregnancy. In: Janz D, Dam M, Richens A, Bossi L, Helge H, Schmidt D, eds. Epilepsy, pregnancy and the child. New York: Raven Press. 251-258.

Janz D. Antiepileptic drugs and pregnancy: altered utilization patterns and teratogenesis. Epilepsia 1982;23(Suppl 1):S53-S62.

Schmidt D. The effect of pregnancy on the natural history of epilepsy: a review of the literature. In: Epilepsy, pregnancy, and the child, Janz D, Bossi L, Dam M, Heige H, Richens A, Schmidt D (eds). Raven Press, New York, 1982 pp. 3-14.

Schmidt D, Canger R, Avanzini G et al. Change of seizure frequency in pregnant epileptic women. Journal of Neurology Neurosurgery and Psychiatry. 1983;46:751-755.

Otani K. Risk factors for the increased seizure frequency during pregnancy and the puerpurium. Fol Psychiar Neurol Japon. 1985;39:33-44.

Ramsay RE, Strauss RG, Wilder BJ, Willmore LJ. Status epilepticus in pregnancy: Effect of phenytoin malabsorption on seizure control. Neurology .1978;28:85-89.

Perruca E, Crema A. Plasma protein binding of drugs in pregnancy. Clinical Pharmacokinetics. 1982;7:336-352.

Dam M, Christiansen J, Munck O, Mygind KJ. Antiepileptic drugs: Metabolism in pregnancy. Clinical Pharmacokinetics.1979;4:53-62.

Philbert A, Dam M. The epileptic mother and her child. Epilepsia. 1982;23:85-99.

Maroni E, Markott R. Epilepsy and pregnancy. Gynaecologia 1969;168:418-21.

Canger R, Avanzini G, Battino D et al. Modifications of seizure frequency in pregnant patients with epilepsy: A prospective study. In: Epilepsy, pregnancy and the child. D Janz, L Bossi, M Dam et al., eds. New York: Raven Press.1982;33-38.

Huhmar E, Jaruinen PA. Relation of epileptic symptoms to pregnancy, delivery and puerperium. Ann Chir Gynaecol Fenn. 1961;50:49-64.

Levy RH, Yerby MS. Effects of pregnancy on antiepileptic drug utilization. Epilepsia 1985;26(suppl 1):525-57.

Lindhout D, Meinardi H, Meijer WA, Nau H. Antiepileptic drugs and teratogenisis in two consecutive cohorts: Changes in prescription policy paralleled by changes in pattern of malformations. Neurology. 1992;42(suppl 5):94-10.

Stumpf DA, Frost M. Seizures, anticonvulsants, and pregnancy. American Journal of Diseases of the Child. 1978;132:746-48.

Burnett CWF. A survey of the relation between epilepsy and pregnancy. Journal of Obstetrics & Gynecology. 1946;53:539-56.

Higgins TA, Commerford JB. Epilepsy and Pregnancy. Journal of the Irish Medical Association. 1974;67(11):317-320.

Suter C, Klingman WO. Seizure states and pregnancy. Neurology.1957;7:105-18.

Teramo K, Hiilesmaa VK. Pregnancy and fetal complications in epileptic pregnancies: Review of the literature. In Epilepsy, pregnancy and the child. D Janz, L Bossi, M Dam et al., eds. New York: Raven Press, 1982;53-59.

Minkoff H, Schaffer RM, Delke I, Grunebaum AN. Diagnosis of intracranial hemorrahge in utero after amaternal seizure. Obstetrics & Gynecology 1985;22S-4S.

Teramo K, Hiilesmaa VK, Bardy A et al. Fetal heart rate during a maternal grand mal epileptic seizure. Journal of Perinatal Medicine. 1979;7:3-5.

Yerby MS, Koepsell T, Daling J. Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia. 1985;:631-635.

Bjerkdal T, Bahna SL: The course and outcome of pregnancy in women with epilepsy. Acta Obstetrics Gynecology Scandanavia. 1973;52:245-248.

Monson RR, Rosenberg L, Hartz SC. Diphenyhydantoin and selected congenital malformations. New England Journal of Medicine. 1973;289:1049--1052.

Montouris GD, Feinchel GM, McLain W. The pregnant epileptic. Archives of Neurology. 1979;36:601-603.

Nelson KB, Ellenberg JH. Maternal seizure disorder, outcome of pregnancy and neurologic abnormalities in the children. Neurology. 1982;32:1247-1254.

Svigos JM. Epilepsy and pregnancy. Australian New Zealand Journal of Obstetrics and Gynaecology. 1984;24:182-185.

Janz D, Fuchs V. Are antiepileptic drugs harmful when given during pregnancy? German Medical Monthly.1964;9:20-22.

Hill RM, Tennyson L. Premature delivery, gestational age, complications of delivery, vital data at birth on newborn infants of epileptic mothers: Review of the literature. In Epilepsy, pregnancy and the child. D Janz, L Bossi, M Dam et al., eds. New York: Raven Press, 1982:167-73.

Kalter H, Warkany J. Congenital malformations. New England Journal of Medicine. 1983;308:491-97.

Egenaes J. Outcome of pregnancy in women with epilepsy, Norway 1967-1978: complications during pregnancy and delivery. In: Epilepsy, Pregnancy, and the Child, Janz D, Dam M, Richens A, et al, (eds.). Raven Press, New York, 1982:81-85.

Yerby MS, Friel PN, McCormick KB, Koerner M, VanAllen M, Leavitt AM, Sells CJ, Yerby JA. 1990 Pharmacokinetics of anticonvulsants in pregnancy: alterations in plasma protein binding. Epilepsy Research. 5:223-228.

Speidel BD, Meadow SR. Maternal epilepsy and abnormalities of the fetus and the newborn. Lancet. 1972;2:839-843.

Knight AH, Rhind EG. Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia. 1975;16:99-110.

Kallen B. A register study of maternal epilepsy and delivery outcome with special reference to drug use. Acta Neurologica Scandinavica 1986; 73(3):253--259.

Tanganelli P, Regesta G. Epilepsy, pregnancy, and major birth anomalies: An Italian prospective, controlled study. Neurology. 1992;42(Suppl 5):89-93.

Mullers-Kuppers Von M. Embryopathy during pregnancy caused by taking anticonvulsants. Acta Paedopsychiatr. 1963;30:401 - 5.

Fedrick J. Epilepsy and pregnancy: a report from the Oxford record linkage study. British Medical Journal. 1973;2:442-448.

Kelly TE. Teratogenicity of anticonvulsant drugs I: Review of the literature. American Journal of Medical Genetics .1984;19:413-34.

Nakane Y, Oltuma T, Takahashi R et al. 1980. Multi-institutional study on the teratogenicity and fetal toxicity of anticonvulsants: A report of a collaborative study group in Japan. Epilepsia.21:663-80.

Philbert A, Dam M. 1982. The epileptic mother and her child. Epilepsia. 23:85-99.

Friis ML, Holm NV, Sindrup EH et al. Facial clefts in the sibs and children of epileptic patients. Neurology 1986;36:346-51.

Robert E, Guibaud P. Maternal valproic acid and congenital neural tube defects. Lancet .1982;11:937.

Rosa F. 1991. Spina bifida in infants of women treated with carbamazepine during pregnancy. New England Journal of Medicine. 324:674-677.

Lindhout D, Omtzigt JG, Cornel MC. Spectrum of Neural tube defects in 34 infants prenatally exposed to antiepileptic drugs. Neurology. 1992;42(4 Suppl 5):111-18.

Lindhout D, Schmidt D. 1986. In-utero exposure to valproate and neural-tube defects. Lancet. 2:1392-1393.

Hiilesmaa VK. Pregnancy and Birth in WWE. Neurology 1992;42(suppl 5):8-11.

Van Creveld S. Nouveaux aspects de la maladie hemorragique du nouveau ne. Ned Tijdschr Geneeskd 1957;101:2109

Mountain KR, Hirsh J, Gallus AS. Maternal cogulation defect due to anticonvulsant treatment in pregnancy. Lancet. 1970;1:265-268.

Deblay MF, Vert P, Andre M et al. Transplacental vitamin K prevents hemorrhagic disease of infants of epileptic mothers. Lancet 1982;1:1247.

Omtzigt JG, et al.Prenatal diagnosis of spina bifida aperta after first-trimester valproate exposure. Prenat Diagn. 1992 Nov;12(11):893-7.

Annegers JF, Elveback LR, Hauser WA et al. 1974. Do anticonvulsants have a teratogenic effect? Archives of Neurology. 31:364-73.

Hill RM, Berniam WM, Morning MG, et al. Infants exposed in utero to antiepileptic drugs. Am J Dis Child. 1974;127:645-652.

Leavitt AM, Yerby MS, Robinson N, Sells CJ, Erickson DM. 1992. Epilepsy and pregnancy: Developmental outcomes at 12 months. Neurology. 142(suppl 5):141-143.

Annegers JF, Hauser WA, Elveback LR, Anderson VE, Kurland LT. 1978. Congenital malformations and seizure disorders in the offspring of parents with epilepsy. International Journal of Epidemiology. 7:241-247.

Ottman R, Annegers JF, Hauser WA, Kurland LT. 1988. Higher risk of seizures in offspring of mothers than fathers with epilepsy. American Journal of Human Genetics. 43:357-364.

Holmes GL, Weber D. Effect of seizures during pregnancy on seizure susceptibility in offspring. Epilepsia 1985;26:421-23.

1-Hauser WA, Hesdorffer DC, Incidence and Prevelence. In: Epilepsy: Frequency, Causes, & Consequences. 1990, Epilepsy Foundation of America, Maryland, pp:1-53.

2-Betts TA, Neuropsychiatry. In: A Textbook of Epilepsy. Ed: John Laidlaw, Alan Richens, Jolyon Oxley, Churchill Livingston, Edinburgh, 1988, pp:350-385.

Dean JC, Penry JK. Weight gain patterns in patients with epilepsy, comparison of antiepileptic drugs. Epilepsia. 1995;36(Suppl 4):72.

Sachdeo R, Kramer LD, Rosenberg A, Sachdeo S. Felbamate monotherpay: controled trial in patients with partial onset seizures. Ann Neurol. 1992;32(3):386-392.

Engelskjon T, Johannessen SI, Kloster R, Nakken KO, Lossius R, Heinriksen O. Long-term effect of topiramate in refractory partial epilepsy. Epilepsia. 1993;34(Suppl 2):123.

Laljee HCK, Parsonage MJ. Unwanted effects of sodium valproate in the treatment of adult patients with epilepsy. In ParsonageMJ, Caldwell ADS, eds. The Place of Sodium Valproate in the Treatment of Epilepsy. London, England: Royal Society of Medicine; 1980:141-158.

Graves NM, Ramsay RE. Phenytoin and Fosphenytoin. In Wyllie E. ed. The Treatment of Epilepsy Second Edition. Baltimore, Maryland: Williams & Wilkins; 1997:833-844.

Aretaeus. The Extant works of Aretaeus, The cappadocian. Libri Septema, Francis Adams translation, 1856:297; quoted in Lennox WG, Lennox MA, Epilepsy and Related Disorders, Vol 2. Little Brown, Boston, 1960:645-646.

Rhomberg MH. A Manual of the Neurvous System of man, Vol 2. Sieveking translation, 1853:205. quoted in Lennox WG, Lennox MA, Epilepsy and Related Disorders, Vol 2. Little Brown, Boston, 1960:646.

Gowers WR. Epilepsy and Other Chronic Convulsive Diseases. Their Causes, Symptoms and Treatment. William Wood, New York, 1885:255.

Dickerson WW. The effect of menstruation on seizure incidence. J. Nerv Ment Dis. 1941;94:160-169

Logothetis J, Harner R, Morrell F, Torres F. The role of estrogens in catamenial epilepsy. Neurology 1958;9:352-60.

Marcus EM, Watson CW, Goldman PL. Effects of steroids on cerebral electrical activity. Arch Neurol 1966;15:521-32.

Backstrom T, Zetterlund B, Blom S, Romano M. Effect of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol Scand 1984;69:240-48.

Graig CR, Anticonvulsant activity of steroids separability of anticonvulsant form hormone effects. J Pharmacol Exp Ther 1966;153:337-43.

Ansell B, Clarke E. Epilepsy and menstruation, the role of water retention. Lancet. 1956;271:1232-35.

Laidlaw J. Catamenial epilepsy. Lancet. 1956;271:1235-37.

Lennox WG, Lennox MA. Epilepsy and related disorders. Vol. 2. Boston. Little Brown, 1960;647.

Rosciszewska D. Analysis of seizure dispersion during menstrual cycle in women with epilepsy. Monogr Neurol Sci, 1980;5:280-4.

Marquez-Assis L. Influence of menstruation on epilepsy. Arq Neuropsiquiatr 1981;39:390-5.

Duncan S, Read CL, Brodie M. How common is catamenial epilepsy? Epilepsia 1993;34:827-31.

Backstrom T. Epileptic seizures in women

Click here to return to start of article.